Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer
Open Access
- 15 March 2013
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 118
Abstract
Background: The purpose of this study is to evaluate the prognostic value of TFPI-2 expression in breast cancer patients through examining the correlation between TFPI-2 expression and breast cancer clinicopathologic features. Methods: Immunohistochemical staining combined with digital image analysis was used to quantify the expression of TFPI-2 protein in breast tumor tissues. For evaluation of the prognostic value of TFPI-2 expression to each clinicopathologic factor, Kaplan-Meier method and COX’s Proportional Hazard Model were employed. Results: TFPI-2 expression was significantly correlated with tumor size, lymph node metastasis, histologic grade, clinical stage, and vessel invasion. More importantly, TFPI-2 expression was also associated with disease-free survival (DFS) of breast cancer patients. We found that patients with high TFPI-2 expression had longer DFS compared with those with low or negative expression of TFPI-2 (P P <0.01). Conclusions: Low or negative expression of TFPI-2 is associated with breast cancer progression, recurrence and poor survival outcome after breast cancer surgery. TFPI-2 expression in breast tumors is a potential prognostic tool for breast cancer patients.Keywords
This publication has 34 references indexed in Scilit:
- The extracellular matrix: A dynamic niche in cancer progressionJournal of Cell Biology, 2012
- Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literatureBMC Cancer, 2009
- Early breast cancerThe Lancet, 2009
- Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cellsExperimental Cell Research, 2004
- Accumulation of uPA – PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancerBritish Journal of Cancer, 2003
- Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosisJournal of Clinical Investigation, 2001
- Metalloproteinases: role in breast carcinogenesis, invasion and metastasisBreast Cancer Research, 2000
- Matrix Localization of Tissue Factor Pathway Inhibitor-2/Matrix-Associated Serine Protease Inhibitor (TFPI-2/MSPI) Involves Arginine-Mediated Ionic Interactions with Heparin and Dermatan Sulfate: Heparin Accelerates the Activity of TFPI-2/MSPI toward PlasminArchives of Biochemistry and Biophysics, 1999
- Inhibitory Properties of a Novel Human Kunitz-Type Protease Inhibitor Homologous to Tissue Factor Pathway InhibitorBiochemistry, 1996
- The Value of Measurement of Pregnancy-Specific Proteins in Twin PregnanciesActa geneticae medicae et gemellologiae: twin research, 1979